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ABSTRACT
Werner syndrome (WS) is a severe recessive
disorder characterized by premature aging, cancer
predisposition and genomic instability. The gene
mutated in WS encodes a bi-functional enzyme
called WRN that acts as a RecQ-type DNA helicase
and a 30-50 exonuclease, but its exact role in DNA
metabolism is poorly understood. Here we show
that WRN physically interacts with the MSH2/MSH6
(MutSa), MSH2/MSH3 (MutSb) and MLH1/PMS2
(MutLa) heterodimers that are involved in the
initiation of mismatch repair (MMR) and the rejec-
tion of homeologous recombination. MutSa and
MutSb can strongly stimulate the helicase activity
of WRN specifically on forked DNA structures with
a 30-single-stranded arm. The stimulatory effect of
MutSa on WRN-mediated unwinding is enhanced
by a G/T mismatch in the DNA duplex ahead of the
fork. The MutLa protein known to bind to the MutS
a–heteroduplex complexes has no effect on WRN-
mediated DNA unwinding stimulated by MutSa,
nor does it affect DNA unwinding by WRN alone.
Our data are consistent with results of genetic
experiments in yeast suggesting that MMR factors
act in conjunction with a RecQ-type helicase to
reject recombination between divergent sequences.
INTRODUCTION
Werner syndrome (WS) is an autosomal recessive dis-
order characterized by an early onset of age-related
pathologies including graying hair, alopecia, arteriosclero-
sis, osteoporosis, diabetes mellitus and cancer (1). The
gene mutated in WS, WRN, encodes a RecQ-type DNA
helicase (2,3). WRN also possesses a 30 - 50 exonuclease
activity residing in a separate domain located at the
N-terminus of the protein (4,5). At the cellular level,
WRN deﬁciency is associated with defects in DNA
replication, homologous recombination (HR) and telo-
mere maintenance (6–9). As a result, cells derived from
WS patients display a high degree of genomic instability
including elevated levels of chromosomal translocations
and deletions (10–13). WS cells are hypersensitive to
DNA-damaging agents such as 4-nitroquinoline 1-oxide,
topoisomerase inhibitors and DNA cross-linkers, suggest-
ing that WRN is actively involved in DNA repair (14–16).
Several lines of evidence implicate WRN in the cellular
response to DNA double-strand breaks (DSBs). WRN
is rapidly recruited to the sites of ionizing radiation
(IR)-induced damage (17). Moreover, it interacts physi-
cally and functionally with a number of proteins that are
involved in the DSB-repair process including the MRE11-
RAD50-NBS1 (MRN) complex (18), the Ku complex
(19), RAD52 (20) and DNA-dependent protein kinase
(21). However, the precise role for WRN in DNA repair
remains to be elucidated.
The DNA mismatch-repair (MMR) system maintains
genomic integrity by correcting DNA replication errors
and preventing recombination between divergent
sequences (22,23). Defects in a subset of MMR genes
including MSH2, MSH3, MSH6, MLH1 and PMS2 are
associated with hereditary non-polyposis colon cancer,
highlighting the crucial role for MMR in genome
maintenance (24). In the initiation step of the eukaryotic
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MMR process, at least three heterodimers, namely
MSH2/MSH6 (MutSa), MSH2/MSH3 (MutSb) and
MLH1/PMS2 (MutLa), are involved (22). MutSa binds
to base-base mismatches and short insertion/deletion
loops, while MutSb can recognize only insertion/deletion
loops containing up to 16 extra nucleotides in one
strand (22). MutLa possesses an intrinsic endonuclease
activity, which is activated upon mismatch recognition
and introduces incisions in the discontinuous strand of the
heteroduplex DNA, generating entry sites for the 50-30
exonuclease EXO1 (25).
Sgs1, the yeast ortholog of WRN, also contributes
to the suppression of recombination between divergent
DNA sequences (26). Heteroduplex rejection during
repair of DSBs by the single-strand annealing pathway
of HR in yeast requires the mismatch binding and ATPase
functions of the Msh2p/Msh6p heterodimer and the
helicase activity of Sgs1 (27,28). These ﬁndings led to the
proposal that MMR proteins act in conjunction with Sgs1
to unwind DNA recombination intermediates containing
mismatches (27,28).
Here we demonstrate that WRN directly interacts
with MutSa, MutSb and MutLa via distinct domains.
MutSa and MutSb are found to stimulate WRN-mediated
unwinding of forked DNA duplexes with a 30-single-
stranded (ss) arm. The stimulatory eﬀect of MutSa on
WRN-mediated unwinding is enhanced by a single G/T
mismatch located in the duplex ahead of the fork in a
manner independent of MutLa. These data provide
biochemical evidence suggesting that the rejection of
homeologous recombination by MMR proteins occurs
via helicase-mediated unwinding of recombination
intermediates.
MATERIALS AND METHODS
Construction of plasmids
The bacterial expression vectors for the WRN fragments
encompassing the amino acid residues 51–449, 949–1432,
500–946, 500–1149, 500–1236, respectively, fused to the
C-terminus of glutathione S-transferase (GST) were con-
structed by PCR ampliﬁcation of corresponding regions of
the WRN cDNA and their insertion in pGEX-2TK
(Amersham Biosciences) between the EcoRI and BamHI
sites. The complete coding region ofWRNwas ampliﬁed by
PCR and cloned in pACT2 (Clontech Palo Alto, CA) via
SmaI site to construct a yeast two-hybrid (YTH) vector
expressingWRNas a fusionwith aGal4 activation domain.
MLH1 cDNA comprised of the codons 500–756was cloned
in a YTH vector pBTM116 (Clontech Palo Alto, CA)
between theEcoRI andSalI sites, resulting in a fusionwith a
LexA DNA binding domain. The pBTM16 derivatives
expressing other MLH1 variants as well as the full-length
yMlh1 were previously described (29). The Gal4-hMSH2
(pLJR105), LexA-MSH3 and LexA-MSH6 bait plasmids
were also described previously (30,31).
Proteins
Recombinant human WRN (3,32), MutSa (33), MutSb
(33) and MutLa (34) and Escherichia coli MutS (35)
were produced and puriﬁed as previously described. An
antibody against the N-terminal region of WRN encom-
passing amino acids 1–391 (ISEV-391) was raised in rabbit
and puriﬁed on an antigen-coupled Sepharose 4A column
(Amersham Biosciences). Control IgGs were puriﬁed from
a rabbit preimmune serum on a 5ml HiTrap protein G-
Sepharose column (Amersham Biosciences).
Cell culture
The following human cell lines were used in this study:
HEK 293 embryonic kidney cells and AG11395
SV40-transformed WS ﬁbroblasts (Coriell Institute for
Medical Research). The HEK 293 cells were maintained in
DMEM (Gibco) supplemented with 10% fetal calf serum
(Biochrome AG). The WS cells were maintained in MEM
containing 15% fetal calf serum and 2mM L-glutamine.
Immunoprecipitation assays
Cells were suspended in lysis buﬀer containing 20mM
Tris–HCl (pH 7.5), 150mM NaCl, 2mM EDTA, 0.1%
(v/v) Triton X-100, 10% (v/v) glycerol and complete,
EDTA-free protease inhibitor cocktail (Roche). After
sonication, the suspension was centrifuged at 20 000 g for
30min at 48C. Aliquots containing 1.6mg of protein were
incubated overnight at 48C with puriﬁed rabbit polyclonal
anti-WRN IgGs (2 mg), which was followed by a 2-h
incubation with protein A/G-agarose beads (Santa Cruz)
at 48C. Where required, extracts were treated with 50 U of
DNaseI (Roche) for 30min at 258C prior to addition of
antibody. After extensive washing with the lysis buﬀer, the
immunoprecipitates were subjected to electrophoresis in a
7.5% polyacrylamide–SDS gel followed by western blot-
ting. The blots were probed with mouse monoclonal
antibodies against WRN (BD Biosciences, 611169),
MSH6 (Pharmingen, clone 44), PMS2 (Pharmingen,
clone 16-4), MLH1 (BD Biosciences, 554073), MSH2
(Calbiochem, clone NA 26) and MSH3 (Transduction
Laboratories, clone 52). Immune complexes were detected
using ECL-plus reagent (Amersham Biosciences), with
horse anti-mouse IgG-horseradish peroxidase conjugate
(Vector) used as a secondary antibody. In the control
experiment, IgGs puriﬁed from a preimmune rabbit serum
were used instead of the anti-WRN antibody.
GST pull-down assays
GST–WRN fusion proteins were produced in the E. coli
BL21-CodonPlus(DE3)-RIL strain (Stratagene) using the
expression vectors described above. The fusion proteins
were bound to glutathione–sepharose beads (Amersham
Biosciences) as previously described (36). The beads were
incubated with 1 mg of puriﬁed MutSa, MutSb or MutLa
in 400 ml of NET-N 100 buﬀer [10mM Tris HCl (pH 8.0),
1mM EDTA, 100mM NaCl, 0.5% (v/v) NP-40] for 2 h at
48C. After extensive washing with NET-N 100 buﬀer,
proteins bound to the beads were analyzed by western
blotting. Membranes were probed with the monoclonal
antibodies described above. MSH3 was detected with a
rabbit polyclonal antibody (NTH3) raised against its ﬁrst
200 amino acids (Eurogentec). In a control experiment,
beads were coated with GST protein only.
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ELISA-based protein binding assay
Puriﬁed recombinant WRN was diluted to a con-
centration of 20 nM in carbonate buﬀer [16mM
Na2CO3, 34mM NaHCO3 (pH 9.6)] and added to wells
of a 96-well microtiter plate (50 ml/well). Plates were
incubated overnight at 48C. For control reactions, wells
were pre-coated with an equivalent amount of bovine
serum albumin (BSA). After aspiration of the samples, the
wells were blocked with blocking buﬀer [phosphate-
buﬀered saline, 0.5% (v/v) Tween-20 and 3% (w/v)
BSA] for 2 h at 378C (200ml/well). Following blockage,
the wells were incubated with increasing concentrations
of puriﬁed recombinant MutSa, MutSb and MutLa
proteins for 1 h at 378C. All samples were supplemented
with ethidium bromide (EtBr) at a concentration of
50 mg/ml to prevent DNA-mediated interactions. Wells
were washed four times with blocking buﬀer to eliminate
unbound proteins, and incubated with the appropriate
primary antibody diluted in blocking buﬀer (mouse
monoclonal anti-MSH2 antibody for MutSa and
MutSb, and mouse monoclonal anti-MLH1 antibody for
MutLa). Plates were incubated for 1 h at 378C. After four
washings with blocking buﬀer, horseradish peroxidase-
conjugated anti-mouse secondary antibody (1:10 000 in
blocking buﬀer) was added and the plates were incubated
at 378C for 30min. After extensive washing with block-
ing buﬀer, the protein complexes were detected using
o-Phenylenediamine dichloride (Sigma) dissolved in 0.1M
citrate-phosphate buﬀer (pH 5.0) containing 0.03%
hydrogen peroxide (1mg/ml). The reactions were termi-
nated after 5min by adding 50 ml of 2M H2SO4. The
plates were scanned in a microplate reader (Molecular
Devices) for absorbance at 492 nm. The A492 values,
corrected for background signal in the presence of BSA,
were plotted as a function of the concentration of
appropriate MMR protein using the GraphPad Prism
software. To determine an apparent dissociation constant
of each complex (Kd), the data points were ﬁtted by the
hyperbolic function Y=BmaxX/(Kd+X) where Bmax is
the maximal binding and Kd is the concentration of ligand
required to reach half-maximal binding.
YTH assay
YTH analysis was carried out using Saccharomyces
cerevisiae strains L40 (MATa trp1 leu2 his3 LYS2::lexA-
HIS3 URA3::lexA-lacZ) and Y190 (MATa, ura3-52,
his3-200, lys2-801, ade2-101, trp1-901, leu2-3, 112, gal4D,
gal80D, cyhr2, LYS2::GAL1UAS-HIS3TATA-HIS3,
URA3::GAL1UAS-GAL1TATA-lacZ). The former strain
was used for LexA-bait vectors while the latter strain
was used for Gal4-bait vectors. Clones carrying the bait
and prey plasmids were tested for b-galactosidase
activity using a pellet X-gal (PXG) assay as previously
described (37).
Helicase assays
Schemes of DNA substrates as well as the sequences
of the constituent oligonucleotides are summarized in
Supplementary Table 1. The f11-20 oligonucleotide
(50-mer) was labeled at the 50-end using T4 polynucleotide
kinase (NEB) and [g-32P]ATP (Amersham Biosciences),
and annealed with appropriate oligonucleotides under
previously described conditions (38). The helicase reaction
mixtures (10 ml) contained 50mM Tris–HCl (pH 7.5),
50mM NaCl, 2mMMgCl2, 50 mg/ml of BSA, 2mM ATP,
1mM DTT, 1 nM DNA substrate and indicated concen-
trations of MMR proteins (MutSa, MutSb, MutLa and
MutS) and WRN. The MMR proteins were pre-incubated
with the DNA substrate on ice for 1min prior to the
addition of WRN. The reactions were incubated at 378C
for 30min and terminated by the addition of 0.5 reaction
volume of buﬀer S [150mM EDTA, 2% (w/v) SDS, 30%
(v/v) glycerol, 0.1% (w/v) bromophenol blue] followed
by treatment with proteinase K (0.1mg/ml) at 378C for
10min. The reaction products were resolved on a
non-denaturing 10% polyacrylamide gel [acrylamide to
bis-acrylamide, 19:1 (w/w)] run in 1xTBE buﬀer at 140V.
Radiolabeled DNA species were visualized by a phos-
phorimager and quantiﬁed using ImageQuant software
(Molecular Dynamics).
RESULTS
Physical association betweenWRN andMMR proteins
Based on genetic studies in yeast, it has been suggested
that the proteins involved in the initiation of MMR act in
conjunction with RecQ DNA helicases to eliminate DNA
recombination intermediates containing mismatches,
which can give rise to chromosomal rearrangements
(27,28). We sought to test the validity of this model
biochemically using the WRN helicase, one of the ﬁve
RecQ homologs identiﬁed in human cells, whose dysfunc-
tion results in chromosomal translocations and deletions.
First, we performed an ELISA-based protein-binding
assay to investigate whether WRN and the MMR proteins
interact physically. Increasing concentrations of puriﬁed
MutSa (MSH2/MSH6), MutSb (MSH2/MSH3) and
MutLa (MLH1/PMS2) proteins (Figure 1A) ranging
from 0 to 80 nM were incubated in wells that had been
pre-coated with WRN at a concentration of 20 nM and
subsequently blocked with BSA to prevent non-speciﬁc
interactions. After extensive washing, the bound MMR
proteins were incubated with speciﬁc antibodies followed
by a colorimetric assay to quantify the binding. In control
experiments, MMR proteins were incubated in wells
pre-coated only with BSA. We found that all the three
MMR heterodimers were speciﬁcally bound to WRN-
coated wells in a dose dependent manner, indicating a
direct interaction (Figure 1B–D). Interestingly, the appar-
ent dissociation constant of the MutSb–WRN complex
(Kd=8.8 nM) was much lower than that estimated for the
MutSa–WRN complex (Kd=38.5 nM). The dissociation
constant of the MutLa–WRN complex (Kd=34.9 nM)
was similar to that of the MutSa–WRN complex.
To test whether WRN and MMR proteins form a
stable complex in vivo, we immunoprecipitated WRN
from extracts of exponentially growing human
embryonic kidney cells (HEK 293) and subjected the
resulting immunoprecipitate to western blot analysis.
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This immunoprecipitate was found to contain the MLH1
and PMS2 proteins, components of the MutLa complex,
but not the MSH2 and MSH6 proteins, which form the
MutSa heterodimer (Figure 2A, lanes 3 and 4). None of
these MMR proteins were detected in the immunoprecip-
itate obtained with control IgGs (Figure 2A, lane 2).
To exclude the possibility that the observed association of
WRN with MLH1 and PMS2 results from independent
binding of these proteins to DNA, we pre-treated the cell
extracts with DNaseI. We found that this treatment did
not alter the level of the MMR proteins in the WRN
immunoprecipitate, suggesting that the WRN–MLH1–
PMS2 complex is mediated by protein–protein interac-
tions (Figure 2A, compare lanes 3 and 4). Furthermore,
we did not detect PMS2 in an immunoprecipitate obtained
with anti-WRN antibody from extracts of the WS cell
line AG11395, excluding the possibility that the observed
co-immunoprecipitation of MMR proteins with WRN is
due to cross-reactivity of the antibody (Figure 2B).
Collectively, these data indicate that MutLa but not
MutSa, forms a stable complex with WRN in vivo.
Mapping of protein–protein interaction domains
To identify the MutSa, MutSb and MutLa-interaction
sites on WRN, we performed aﬃnity pull-down assays
using a series of WRN fragments fused to GST. These
fragments covered the entire WRN polypeptide except for
the ﬁrst 50 amino acids and the region spanning the amino
acids 450–499 (Figure 3A and B). The GST pull-down
experiments revealed that the MutSa interaction site on
WRN was localized to the region between amino acids
500 and 946, which constitutes the helicase core of WRN
composed of the DExH helicase and Zn-binding domains
(Figure 3A and C). MutSb was found to make contacts
not only with the helicase core of WRN, but also with a
region spanning amino acids 947–1149 that contains the
winged-helix (WH) motif, a common interaction site for
most of the WRN partners identiﬁed thus far (Figure 3A
and C) (39). Notably, the binding aﬃnity of MutSb to
the WH domain of WRN appeared to be much higher
that its binding aﬃnity to the helicase core of WRN
(Figure 3C, compare lanes 4–7). The data also indicated
that MutSb binds to WRN more eﬃciently than MutSa
(Figure 3C, top and middle panels; compare lane 1 with
lanes 4–7), which is in agreement with the results of the
ELISA assay (Figure 1).
MutLa was found to interact with the helicase core of
WRN and with the N-terminal portion of WRN including
the exonuclease domain, showing a higher binding aﬃnity
to the former domain (Figure 3A and C, bottom panel;
compare lanes 3–7).
To identify the subunits of MutSa, MutSb and MutLa
that mediate the interaction with WRN, we performed a
quantitative YTHassay with the full-length WRN as prey.
The following interactions were examined: MSH2–WRN,
MSH6–WRN, MSH3–WRN and MLH1–WRN.
Figure 1. Direct physical interaction of WRN with MMR proteins. (A) SDS–PAGE analysis of puriﬁed recombinant MutSa, MutSb, MutLa and
WRN proteins produced in insect cells by means of the baculovirus system. (B) Binding of MutSa to WRN as a function of MutSa concentration.
(C) Binding of MutSb to WRN as a function of MutSb concentration. (D) Binding of MutLa to WRN as a function of MutLa concentration.
Increasing concentrations of MutSa, MutSb and MutLa (0–80 nM) were incubated at 378C for 1 h in the wells of an ELISA plate that were pre-
coated with the WRN protein (20 nM) and subsequently blocked with 3% BSA. After extensive washing, the bound MMR proteins were detected by
ELISA as described in Materials and Methods. The measured absorbance values were corrected by subtracting background values obtained with
BSA-coated wells. The data points represent the mean of three independent experiments.
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We found WRN to interact with MLH1 and MSH2, but
not with MSH3 and MSH6 (Figure 4A and B). This
indicates that the MutSa–WRN and MutSb–WRN
interactions are mediated by MSH2, and the MutLa–
WRN interaction is mediated by MLH1. However, the
inability of MSH3 and MSH6 to interact with WRN in
the YTH assay could be a consequence of the fact that
these proteins are not soluble when expressed alone (33).
This is also true for PMS2 (34). Therefore, the possibility
still exists that these proteins could make additional
contacts with WRN. This is particularly likely in the case
of MSH3, since our GST pull-down experiments revealed
that MutSb interacts with both the helicase core and the
WH domain of WRN, whereas MutSa interacts only with
the helicase core of WRN (Figure 3).
In order to identify the WRN interaction domain on
MLH1, we tested a series of MLH1 deletion variants for
the ability to interact with the full-length WRN in YTH
assay. We found that this domain is located at the
C-terminus of the MLH1 polypeptide between amino
acids 500 and 756 (Figure 4A and B). This is diﬀerent
from the location of the BLM-interaction site that was
mapped to the region spanning amino acids 396–500 (29).
Stimulation of the helicase activity ofWRN byMutSa
andMutSb
Next, we tested MutSa for the ability to aﬀect the helicase
activity of WRN on DNA substrates containing mis-
matches. In these experiments, we used a synthetic DNA
duplex (49 bp) with a 30-ss ﬂap (19 nt) resembling a part of
the structure that results from annealing of the resected
arms of a broken chromosome at regions of homology.
On such forked DNA structures, WRN preferentially
translocates along the 30-ﬂap oligonucleotide to unwind
the duplex ahead of the fork junction, generating a
30-tailed duplex. This primary product can be further
unwound by WRN into the component strands, as a
consequence of loading of a second helicase molecule on
the 30-ssDNA tail (40). We prepared a fully matched
substrate and a substrate containing a single G/T
mismatch located 11 nt ahead of the ss/ds junction
(Figure 5A and B, top panels). WRN alone displayed a
very low helicase activity on both structures when present
at the same concentration as the DNA substrate (1 nM).
However, the helicase activity of WRN on these structures
dramatically increased upon inclusion of an 8-fold
molar excess of MutSa in the reaction (Figure 5A–D).
Notably, the initial rate of the MutSa-stimulated un-
winding reaction with G/T substrate was about 1.7 times
higher than that measured with the G/C substrate
(Supplementary Table 2).
Since MutLa is known to bind to MutSa–heteroduplex
complexes (41), we investigated whether it can aﬀect the
WRN-mediated unwinding of G/T and G/C substrates
induced by MutSa. We found that MutLa did not
signiﬁcantly alter the MutSa-dependent helicase activity
of WRN on these DNA structures (Figure 5). Also, it had
no eﬀect on WRN-mediated unwinding in the absence of
MutSa (Figure 7, lane 5).
To further assess the eﬀect of MutSa on WRN-
mediated unwinding of the 30-ﬂap duplex, we performed
a protein titration experiment, in which we varied the
concentration of MutSa while keeping WRN and DNA
substrate at a ﬁxed concentration of 1 nM. We found that
MutSa stimulated the helicase activity of WRN in a
concentration-dependent manner, exhibiting a signiﬁ-
cantly higher activity on the G/T substrate than on the
homoduplex substrate (Figure 6).
To explore the speciﬁcity of the observed stimulatory
eﬀect, we tested human MutSb as well as E. coli MutS
for the ability to stimulate DNA unwinding by WRN.
We found that MutSb enhanced the WRN-mediated
unwinding of the 30-ﬂap DNA duplex to a similar extent
Figure 2. WRN forms a stable complex with MLH1 and PMS2 in
human cells. (A) Western blot analysis of WRN immunoprecipitates
from total extracts of HEK 293 cells (1.6mg of protein) before (lane 3)
and after (lane 4) treatment with DNaseI (50 U). Lane 1, 5% of input;
lane 2, control immunoprecipitation experiment with a preimmune
rabbit IgGs. Puriﬁed rabbit anti-WRN IgGs (2mg) were used to
immunoprecipitate WRN. Blots were probed with monoclonal anti-
bodies against WRN, MSH2, MSH6, MLH1 and PMS2. (B) Western
blot analysis of immunoprecipitate from extracts of AG11395
(WRN/) cells obtained using an anti-WRN antibody. The immuno-
precipitations were carried out under the same conditions as in (A). The
blots were probed with a monoclonal antibody against PMS2.
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as seen with MutSa (Figure 7, compare lanes 2 and 3).
In contrast, the E. coli MutS protein did not enhance the
WRN-mediated DNA unwinding (Figure 7, lane 8),
indicating that the observed stimulatory eﬀect is speciﬁc
to human MutS homologs. As in the case of MutSa,
MutSb-stimulated helicase activity of WRN was not
inﬂuenced upon addition of MutLa (Figure 7, compare
lanes 4 and 7) and it was dependent on MutSb
concentration (Supplementary Figure S1). We also
found that in the presence of MutSb, WRN unwound
the G/T substrate with the same eﬃciency as the
homoduplex substrate (Supplementary Figure S2). This
is consistent with the fact that MutSb does not bind to
base–base mismatches (22) and supports the conclusion
that the observed stimulatory eﬀect of the G/T mismatch
on MutSa-dependent unwinding of the 30-ﬂap duplex by
WRN results from the speciﬁc binding of MutSa to the
mismatch.
Together, the results described above indicate that
MutSa and MutSb, but not MutLa, can stimulate WRN
to unwind DNA structures resembling recombination
intermediates and that this stimulatory eﬀect is enhanced
by mismatches in the DNA substrate.
MutSa andMutSb stimulateWRN helicase specifically
on forked DNA duplexes with a 30-ss arm
To gain further insights into the mechanism underlying
the stimulation of the helicase activity of WRN by MutSa
and MutSb, we investigated the dependence of this
reaction on the conﬁguration of the arms of the fork.
Using the same set of oligonucleotides, we prepared the
following substrates: a forked duplex with both arms
single stranded (splayed arm); a forked duplex with the
30-arm single stranded and the 50-arm double stranded
(30-ﬂap duplex); a forked duplex with the 30-arm double
stranded and the 50-arm single stranded (50-ﬂap duplex)
and a forked duplex with both arms double stranded.
Earlier studies revealed that WRN could unwind eﬃ-
ciently all these structures, indicating that it does not
require the 30-arm to be single stranded for loading at the
fork (40). We found that MutSa and MutSb strongly
stimulated the WRN-mediated unwinding of the splayed
arm and the 30-ﬂap duplex, but had no signiﬁcant eﬀect
on the unwinding of the 50-ﬂap duplex and the fully double
stranded fork (Figure 8). We also tested these proteins for
the ability to stimulate the helicase activity of WRN on
30-ssDNA-tailed duplex, which is normally a poor
substrate for WRN (40). We found that neither MutSa
nor MutSb could activate WRN for unwinding of this
partial DNA duplex (data not shown). Interestingly, the
30-tail duplex resulting from unwinding of the 30-ﬂap
structure was unwound by WRN eﬃciently. This dis-
crepancy can result from the fact that WRN exists as
an oligomeric structure, which would facilitate loading
of a second molecule of WRN on the 30-ssDNA generated
by unwinding of the duplex ahead of the fork.
Collectively, these data indicate that MutSa and
MutSb require a forked DNA structure with 30-ss DNA
at the junction to stimulate WRN-mediated DNA
unwinding.
Figure 3. Mapping of MutSa, MutSb and MutLa-interaction domains on WRN (A) Domain organization of the WRN protein. Exo, exonuclease
domain; DExH, helicase domain; Zn, zinc-binding domain; WH, winged-helix domain; HRDC, helicase and RNaseD C-terminal domain; RQC,
RecQ C-terminal region. The black lines indicate the boundaries of the various WRN fragments used in this study. (B) SDS–PAGE analysis of GST–
WRN fragments expressed in E. coli and isolated using glutathione beads. Bands migrating below the WRN fragments (marked by an asterisks) were
determined to be degradation products by western blot analysis using an anti-GST antibody. (C) GST pull-down assay. Glutathione beads coated
with the indicated GST-tagged WRN fragments were incubated with puriﬁed MutSa, MutSb or MutLa proteins expressed in insect cells using
baculovirus system and the bound MMR proteins were analyzed by western blotting as described in Materials and Methods.
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DISCUSSION
Although WRN has been implicated in a number of DNA
repair processes, the exact DNA transactions mediated
by this helicase/exonuclease in the cell remain elusive.
Here we show that WRN interacts physically with
proteins that are involved in the initiation of MMR and
the rejection of recombination between divergent
sequences. Most importantly, our experiments revealed
that MutSa and MutSb can stimulate the helicase activity
of WRN on forked DNA structures with a 30-ss arm that
resemble intermediates of single-strand annealing path-
ways of HR. In addition, we found that a single G/T
mismatch located ahead of the fork junction increased the
eﬃciency of the MutSa-dependent unwinding by WRN.
These data are consistent with a model in which the MMR
initiation factors prevent homeologous recombination by
activating a DNA helicase for unwinding of recombina-
tion intermediates containing mismatches. This model
was proposed earlier on the basis of results of in vivo
heteroduplex rejection assays with yeast msh2 and sgs1
mutants (27,28). It is possible that MutSa and MutSb
bind to mismatches formed after pairing of sequences
of imperfect homology and, following ATP binding, are
converted into a DNA sliding clamp as proposed in the
case of the MMR pathway (42). When the clamp
encounters the junction between the heteroduplex and
the non-homologous 30-SS tail, it binds stably to it and
recruits a DNA helicase to disrupt the joined DNA
molecule. In agreement with this hypothesis, it has been
demonstrated that yeast MutSb speciﬁcally binds to
forked DNA structures containing 30- ssDNA making
contacts with the sequences at the ds–ss junction (43).
These studies also revealed that MutSb holds the junction
in an altered, perhaps more rigid, conformation (43). Such
structural changes could facilitate the loading of the WRN
helicase on the 30- ssDNA at the junction, which is a
prerequisite for duplex unwinding to occur. However,
it should be noted that the MutSa-activated unwinding
of a 30-ﬂap duplex by WRN displayed only a moderate
dependence on mismatches. It is therefore possible that
hereroduplex rejection in vivo involves some additional
factors that ensure mismatch speciﬁcity of this
transaction.
In our studies, we did not observe any signiﬁcant
modulation of WRN-mediated unwinding by MutLa,
even in the presence of MutSa or MutSb. In agreement
with this ﬁnding, the yeast Mlh1 and Pms1 proteins have
been shown to have only minor roles in the rejection of
homeologous recombination relative to the contributions
of Msh2 and Msh6 (27). Thus, it appears that the physical
interaction between WRN and MutLa identiﬁed in this
study has some other functional implication. Interestingly,
MLH1 was shown to interact with various DNA repair
factors including MRE11, BACH1, MBD4 and BLM
(29,44–47). It is, therefore, possible that MLH1 plays a
more general role in DNA repair processes.
A number of other functional implications for the
observed interactions between WRN and the MMR
factors can be discussed. Several lines of evidence suggest
that WRN promotes replication of telomeric DNA
by unwinding G-quadruplex structures that can readily
form in G-rich telomeric DNA and impose a barrier
for progression of DNA replication forks (9,48–50).
Strikingly, human MutSa has been shown to bind
eﬃciently to G-quadruplex DNA (51). Moreover, Msh2
deﬁciency in mice is associated with loss of telomeres
and an elevated level of telomere end-to-end fusion, a
phenotype similar to that manifested by WRN-deﬁcient
Figure 4. Interaction between WRN and MMR proteins in yeast two-
hybrid system. (A) Domain organizations of the MSH2 and MLH1
proteins. The numbers refer to the amino acid sequence.
(B) Quantitative yeast two-hybrid assay. The S. cerevisiae strain L40
harboring a pACT2 vector expressing the full-length WRN fused to the
GAL4 activation domain was transformed with pBTM116 vectors
encoding the indicated MMR proteins fused to LexA (MLH1 and its
deletion derivatives, MSH3 and MSH6) or Gal4 (MSH2) DNA binding
domains. Clones containing both plasmids were subjected to
b-galactosidase assay on an ELISA micro-plate using 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside (X-gal) as a substrate. Top
panel: An ELISA plate after a 30-min incubation at room temperature.
Bottom panel: Graph showing absorbance at 615 nm measured in
individual wells after 35min, which is a measure of b-gal activity. The
values represent the mean of three independent experiments.
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cells (9,52). Thus, one can speculate that the
MMR proteins can mediate recruitment of the WRN
helicase to G-quadruplex structures formed at telomeres
and hence facilitate their removal.
It has been shown that the human MutSb and WRN are
required along with PCNA, RPA and ERCC1-XPF
for uncoupling of psoralen-induced inter-strand DNA
crosslinks (ICLs) in cell-free extracts, suggesting a novel
ICL-repair pathway in which MutSb is essential for the
recognition of ICLs, while the WRN helicase mediates
unwinding of the DNA duplex adjacent to the lesion,
which enables strand incision by ERCC1-XPF (53,54).
Our ﬁnding that MutSb physically interacts with WRN
and stimulates its helicase activity brings further support
for this model and suggests that MutSb might recruit
WRN to the ICL sites.
Earlier studies demonstrated that nuclear extracts from
several ﬁbroblastoid cell lines derived from WS patients
were deﬁcient in repair of base–base mismatches and
insertion/deletion loops, suggesting that WRN could have
a role in MMR (55). However, it is not certain that
the MMR-deﬁciency of these extracts was caused
solely by WRN deﬁciency because complementation
experiments with recombinant WRN protein were not
performed in this study. Moreover, in some cases, pair-
wise mixing of these extracts restored MMR proﬁciency,
making the involvement of WRN in MMR rather
questionable.
Recently, two other human RecQ homologs, namely
RECQ1 and BLM, have been shown to interact physically
and functionally with the MMR-initiation factors
(29,31,47,56,57). As in the case of WRN, MutSa was
found to stimulate RECQ1-mediated unwinding of a
forked structure with a 30-ss arm (56). In contrast, MutSa
did not aﬀect unwinding of forked DNA duplexes by
BLM (31). Instead, MutSa was found to stimulate the
ability of BLM to process Holliday junctions in vitro (57).
Further studies will be needed to fully understand the
molecular mechanisms by which the RecQ helicases and
MMR factors work together to maintain genomic
stability.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 5. Kinetics of WRN-mediated unwinding of a 30-ﬂap DNA duplex in the presence of MutSa and MutLa. (A) Reactions with a homoduplex
30 ﬂap substrate. (B) Reactions with a 30-ﬂap duplex containing a G/T mismatch located 11 nucleotides ahead of the fork as indicated.
(C) Quantiﬁcation of the time course reactions in A. (D) Quantiﬁcation of the time course reactions in B. All reactions contained 1 nM [32P]DNA,
1 nM WRN and 8 nM MMR proteins as indicated. Aliquots at individual time points were analyzed by native PAGE followed by phosphorimaging
and quantiﬁcation as described in Materials and Methods section. Schemes of the substrate and the reaction products are shown on the right. The
relative concentration of unwound products (30-tailed duplex and free labeled oligonucleotide) is expressed as a percentage of total DNA.
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